December 08, 2015
Article
Did you know that health plans completely cover certain OTC products when patients present a prescription?
December 04, 2015
Warnings about the risk of ketoacidosis and serious urinary tract infections have been added to the labels of SGLT2 inhibitors.
December 02, 2015
FDA previously recommended Qualgen cease all sterile compounding until it corrected unsanitary conditions and poor sterile production practices.
December 01, 2015
Qualgen has taken corrective actions concerning its compounding facility conditions and sterility processes.
October 29, 2015
The FDA has once again delayed its enforcement of product tracing requirements for pharmacies.
October 03, 2015